Macrophage Polarization, Annu Rev Physiol, vol.79, pp.541-566, 2017. ,
Monocyte and macrophage heterogeneity, Nat Rev Immunol, vol.5, pp.953-964, 2005. ,
Macrophage plasticity and polarization: in vivo veritas, J Clin Invest, vol.122, pp.787-795, 2012. ,
Update on the use of immunoglobulin in human disease: A review of evidence, J Allergy Clin Immunol, vol.139, pp.1-46, 2017. ,
Passive serum therapy to immunomodulation by IVIG: A fascinating journey of antibodies, J Immunol, vol.200, pp.1957-1963, 2018. ,
URL : https://hal.archives-ouvertes.fr/inserm-02455445
IVIG-mediated effector functions in autoimmune and inflammatory diseases, Int Immunol, vol.29, pp.491-498, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01723555
Intravenous immunoglobulin therapy: how does IgG modulate the immune system?, Nat Rev Immunol, vol.13, pp.176-189, 2013. ,
What is the contents of the magic draft IVIg?, Autoimmun Rev, vol.7, pp.435-439, 2008. ,
Therapeutic antibodies for autoimmunity and inflammation, Nat Rev Immunol, vol.10, pp.301-316, 2010. ,
Anti-CD20 monoclonal antibodies: reviewing a revolution, Hum Vaccin Immunother, vol.14, pp.2820-2841, 2018. ,
Repressing immunity in autoimmune disease, N Engl J Med, vol.374, pp.2090-2092, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-02455469
Revisiting IL-2: Biology and therapeutic prospects, Sci Immunol, vol.3, p.1482, 2018. ,
The future of immunotherapy: A 20-year perspective, Front Immunol, vol.8, p.1668, 2018. ,
Kill 'Em All: Efgartigimod immunotherapy for autoimmune diseases, Trends Pharmacol Sci, vol.39, pp.919-922, 2018. ,
URL : https://hal.archives-ouvertes.fr/inserm-02455435
Antigen-specific immunotherapies in rheumatic diseases, Nat Rev Rheumatol, vol.13, pp.525-537, 2017. ,
Multimerized IgG1 Fc molecule as an anti-inflammatory agent, Nat Rev Rheumatol, vol.14, pp.390-392, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01835524
Tregitope: Immunomodulation powerhouse, Hum Immunol, vol.75, pp.1139-1146, 2014. ,
Trends involving monoclonal antibody (mAb) research and commercialization: A scientometric analysis of IMS Lifecycle R&D Focus Database (1980-2016), Hum Vaccin Immunother, vol.14, pp.847-855, 2018. ,
Intravenous gammaglobulin inhibits encephalitogenic potential of pathogenic T cells and interferes with their trafficking to the central nervous system, implicating sphingosine-1 phosphate receptor 1-mammalian target of rapamycin axis, J Immunol, vol.190, pp.4535-4541, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-02455535
Protection in antibody-and T cellmediated autoimmune diseases by antiinflammatory IgG Fcs requires type II FcRs, Proc Natl Acad Sci. USA, vol.112, pp.2385-2394, 2015. ,
Regulatory T cell frequency, but not plasma IL-33 levels, represents potential immunological biomarker to predict clinical response to intravenous immunoglobulin therapy, J Neuroinflammation, vol.14, p.58, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01502272
Regulatory T cells induce activation rather than suppression of human basophils, Sci Immunol, vol.3, p.829, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01817714
Intravenous immunoglobulin induces IL-4 in human basophils by signaling through surface-bound IgE, J Allergy Clin Immunol, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02284256
Circulating normal IgG as stimulator of regulatory T cells: Lessons from intravenous immunoglobulin, Trends Immunol, vol.38, pp.789-792, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01630293
Regulatory T cell epitopes (Tregitopes) in IgG induce tolerance in vivo and lack immunogenicity per se, J Leukoc Biol, vol.94, pp.377-383, 2013. ,
Monomeric immunoglobulin A from plasma inhibits human Th17 responses in vitro independent of Fc?RI and DC-SIGN, Front Immunol, vol.8, p.275, 2017. ,
Peripherally generated Foxp3+ regulatory T cells mediate the immunomodulatory effects of IVIg in allergic airways disease, J Immunol, vol.198, pp.2760-2771, 2017. ,
Intravenous immunoglobulin protects from experimental allergic bronchopulmonary aspergillosis via a sialylationdependent mechanism, Eur J Immunol, vol.49, pp.195-198, 2019. ,
URL : https://hal.archives-ouvertes.fr/inserm-02455434
Selective induction of interleukin-1 receptor antagonist and interleukin-8 in human monocytes by normal polyspecific IgG (intravenous immunoglobulin), Eur J Immunol, vol.25, pp.1267-1273, 1995. ,
Fc?RIII-dependent inhibition of IFN? responses mediates suppressive effects of intravenous immune globulin, Immunity, vol.26, pp.67-78, 2007. ,
Heme oxygenase-1 is dispensable for the antiinflammatory activity of intravenous immunoglobulin, Sci Rep, vol.6, p.19592, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01274079
IVIg and LPS co-stimulation induces IL-10 production by human monocytes, which is compromised by an Fc?RIIA disease-associated gene variant, Front Immunol, vol.9, p.2676, 2018. ,
Intravenous immunoglobulin skews macrophages to an anti-inflammatory, IL-10-producing activation state, J Leukoc Biol, vol.98, pp.983-994, 2015. ,
Gene expression profiling of the effect of high-dose intravenous Ig in patients with Kawasaki disease, J Immunol, vol.174, pp.5837-5845, 2005. ,
Enhanced gene expression of chemokines and their corresponding receptors in mononuclear blood cells in chronic heart failure--modulatory effect of intravenous immunoglobulin, J Am Coll Cardiol, vol.38, pp.187-193, 2001. ,
Mphi1 and Mphi2 can be re-polarized by Th2 or Th1 cytokines, respectively, and respond to exogenous danger signals, Immunobiology, vol.211, pp.473-486, 2006. ,
Macrophage polarization drives granuloma outcome during Mycobacterium tuberculosis infection, Infect Immun, vol.83, pp.324-338, 2015. ,
Differences in antionflammatory actions of intravenous immunoglobulin between mice and men: more than meets the eye, Front Immunol, vol.6, p.197, 2015. ,
Molecular and immunological biomarkers to predict IVIg response, Trends Mol Med, vol.21, pp.145-147, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01117084
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats, J Neuroinflammation, vol.15, p.232, 2018. ,
Intravenous immunoglobulin promotes antitumor responses by modulating macrophage polarization, J Immunol, vol.193, pp.5181-5189, 2014. ,
IVIG pluripotency and the concept of Fc-sialylation: challenges to the scientist, Nat Rev Immunol, vol.14, p.349, 2014. ,
URL : https://hal.archives-ouvertes.fr/inserm-02455513
Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation, Science, vol.313, pp.670-673, 2006. ,
Identification of a receptor required for the anti-inflammatory activity of IVIG, Proc Natl Acad Sci U S A, vol.105, pp.19571-19578, 2008. ,
Dendritic cell immunoreceptor: a novel receptor for intravenous immunoglobulin mediates induction of regulatory T cells, J Allergy Clin Immunol, vol.133, pp.853-863, 2014. ,
IVIg modulates BCR signaling through CD22 and promotes apoptosis in mature human B lymphocytes, Blood, vol.116, pp.1698-1704, 2010. ,